Vangoori Yakaiah, Suresh Babu Sayana, Midde Madhavi Latha, Anusha D, Uppala Praveen Kumar
Santhiram Medical College, Nandyal (AP), India.
Govt. Medical College, Suryapet, Telangana, India.
Maedica (Bucur). 2022 Sep;17(3):706-713. doi: 10.26574/maedica.2022.17.3.706.
Obesity is defined by an imbalance between energy expenditure and energy consumption. Presently, it is considered a global problem because people are consuming junk food and doing less physical activity in every country of the world. It is all due to sedentary life style. The currently available drugs for the treatment of obesity are not giving satisfactory results as they have many adverse effects along with rebound obesity complications. To evaluate new drug in pre-clinical study, we need to have better supportive animal models. Obesity can be induced by giving drugs, fat food, surgical procedures, and by genetic modifications. In the present review, various obesity induced models have been explained to evaluate new compounds. In experimental animal models, monogenic and polygenic obesity models have been reviewed, with a proper pathway to prepare new drugs being given. While in the existing models, genetic obesity models were not explained so far, here genetic engineered transgenic models were described to evaluate new anti-obesity drugs. This short review on chemically and surgically induced obesity models aimed to provide a better understanding of the experimental design of obesity.
肥胖是由能量消耗和能量摄入之间的失衡所定义的。目前,它被视为一个全球性问题,因为在世界上每个国家,人们都在食用垃圾食品且身体活动较少。这完全归因于久坐不动的生活方式。目前用于治疗肥胖的药物并未取得令人满意的效果,因为它们伴随着许多不良反应以及反弹肥胖并发症。为了在临床前研究中评估新药,我们需要有更好的支持性动物模型。肥胖可以通过给药、高脂肪食物、手术程序以及基因改造来诱发。在本综述中,已对各种诱导肥胖的模型进行了解释,以评估新化合物。在实验动物模型中,对单基因和多基因肥胖模型进行了综述,并给出了制备新药的适当途径。而在现有模型中,迄今为止尚未对遗传性肥胖模型进行解释,在此描述了基因工程转基因模型以评估新型抗肥胖药物。这篇关于化学和手术诱导肥胖模型的简短综述旨在更好地理解肥胖的实验设计。